Lhermitte's sign following oxaliplatin-containing chemotherapy in a cisplatin-pretreated ovarian cancer patient.
Ciucci
G
G
De Giorgi
U
U
Leoni
M
M
Bianchedi
G
G
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D009333:Neck; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D010051:Ovarian Neoplasms / Q000503:physiopathology* / Q000628:therapy*; D000077150:Oxaliplatin; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced / Q000150:complications; D012399:Rotation; D012678:Sensation Disorders / Q000139:chemically induced*
D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D002945:Cisplatin